The Latest Cardiac and Vascular News
Part of the Viz PE Solution, new algorithm flags key patient risk indicator of pulmonary embolism severity SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an automated RV/LV ratio algorithm, a seamless […]
BALTIMORE, Sept. 1, 2022 /PRNewswire/ — i-Cordis, LLC, an early-stage pharmaceutical company, has been awarded a Phase II Small Business Innovation Research (SBIR) grant for $1,548,708 from the National Heart, Lung, and Blood Institute (NHLBI) to further develop a potential immune-modulatory treatment for Heart Failure with preserved Ejection Fraction (HFpEF). HFpEF is one of […]
HANGZHOU, China, Sept. 1, 2022 /PRNewswire/ — On August 31, 2022, Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as “Venus Medtech”), a leading provider of integrated solutions for transcatheter structural heart valvular therapies in China, announced its interim results for the six months ended June 30, 2022. Under repeated COVID-19 outbreaks, Venus Medtech intensified its […]
Michael Alexanian joins Gladstone Institutes to discover new targets for treating and reversing heart failure SAN FRANCISCO, Sept. 1, 2022 /PRNewswire/ — A healthy human heart is a powerful, pliable organ that expands and contracts rapidly to pump rich, oxygenated blood through the body. But for the millions of people around the world […]
The innovative pre-stent standardizes the shape of the pulmonary valve opening, allowing for a higher number of patients to be candidates for transcatheter valve replacement. TAMPA, Fla., Aug. 30, 2022 /PRNewswire/ — Erin Ambrose knew the day would come. The day she would once again watch her daughter, Hailey, be wheeled into an operating […]
KFAR SABA, Israel and SANTA CLARA, Calif., Aug. 31, 2022 /PRNewswire/ — Sensifree LTD, a world innovator in advanced hemodynamic monitoring (“Sensifree”), received CE certificate for SentiCor-100® in compliance with the new EU MDR. SentiCor-100® is the world’s first PPG based Continuous Non-Invasive Blood Pressure (cNIBP) monitoring device approved for hospital use. “This is an important landmark […]
Financing Secures Funding to Complete ALIGN-AR Clinical Trial, Continue E.U. Real World Evidence Development, and Prepare for a U.S. Commercial Launch IRVINE, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) — JenaValve Technology, Inc. (“JenaValve or the “Company”), developer and manufacturer of differentiated transcatheter aortic valve replacement (TAVR) systems, today announced that […]
IRVINE, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced planned enrollment of the DEFIANCE trial. DEFIANCE is a randomized controlled trial (“RCT”) comparing […]
LAKE OSWEGO, Ore., Aug. 31, 2022 /PRNewswire/ — BIOTRONIK’s LiveSupport feature has been successfully used to remotely support Cardiac Rhythm Management (CRM) clinics. This new technology enables BIOTRONIK representatives to provide programmer support from remote locations, allowing for faster support for clinics and addressing concerns around in-person contact brought on by the […]
Partnership reflects commitment to patient safety; BioButton® wearable offers up to 1,440 vital signs measurements daily, monitoring patients transitioning from higher to lower acuity settings Technology complements the Medtronic Patient Monitoring business’ HealthCast™ intelligent patient manager portfolio designed for connectivity, visualization, remote patient monitoring, and now, wearables DUBLIN, Aug. 31, 2022 /PRNewswire/ […]
